Items where Author is "Guirguis, Amira"

Number of items: 100.
Article
  • GLP-1 and dual GIP/GLP-1 receptor agonists’ psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill–informed, systematic, evaluation. (2026) Fabrizio Schifano, Maria Antonietta De Luca, Stefania Bonaccorso, Davide Arillotta, Giuseppe Floresta, Giovanni Martinotti, Gabriele Duccio Papanti, John Martin Corkery, Stefania Chiappini and Amira Guirguis picture_as_pdf
  • Possible signals of ocular disorders associated with gabapentinoids: A three-arm study. (2026) Mya Murray, Amira Guirguis, Paul Deslandes, John Martin Corkery, Stefania Chiappini, Mariacristina Parravano and Fabrizio Schifano picture_as_pdf
  • Psychopharmacology of Methamphetamine in Relation to the United Kingdom Sentencing Guidance: Comparative Analysis with Amphetamine, Cocaine and Heroin. (2026) Amira Guirguis, Arianna Giorgetti, Jegak Seo, John Martin Corkery and Fabrizio Schifano
  • Psychopharmacology of Methamphetamine in Relation to UK Sentencing Guidance: Comparative Analysis with Amphetamine, Cocaine and Heroin. (2026) Amira Guirguis, Arianna Giorgetti, Jegak Jegak, John Martin Corkery and Fabrizio Schifano picture_as_pdf
  • Tolazoline, an alpha-adrenergic antagonist, may also block xylazine at off-target sites as inferred from molecular docking. (2026) Giuseppe Floresta, Vincenzo Patamia, Alberto Granzotto, Davide Arillotta, Gabriele Duccio Papanti, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano picture_as_pdf
  • Deaths involving gabapentin and pregabalin, Scotland, 2000-2024: a descriptive account. (2026) John Martin Corkery, Amira Guirguis and Fabrizio Schifano picture_as_pdf
  • Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment. (2026) Stefania Chiappini, John Martin Corkery, Amira Guirguis, Alessio Mosca, Mya Murray, Davide Arillotta, Luigi Dattoli, Giovanni Martinotti, Stefania Bonaccorso, Fabrizio Schifano and Nicolo Schifano
  • Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database. (2026) Mya Murray, Fabrizio Schifano, Stefania Chiappini, John Martin Corkery and Amira Guirguis picture_as_pdf
  • Reply to comment on: “Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists: an examination of the FAERS database”. (2026) Mya Murray, Fabrizio Schifano, Stefania Chiappini, John Martin Corkery and Amira Guirguis picture_as_pdf
  • Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic : Implications for Central Effects. (2026) Maria Antonietta De Luca, Cristina Miliano, Amanda Roxburgh, Myfanwy Graham, Francesca Caria, Amira Guirguis, Fabrizio Schifano, Suzanne Nielsen, Nicola Simola and Giulia Costa picture_as_pdf
  • Ketamine-related deaths registered in Scotland 2013-2024. (2026) John Martin Corkery, Amira Guirguis and Fabrizio Schifano
  • Possible eye disorders in children prenatally exposed to either methadone or buprenorphine in comparison with other medications; an examination of the Food and Drug Administration (FDA) pharmacovigilance database. (2025) Stefania Chiappini, Laura Orsolini, John Martin Corkery, Amira Guirguis, Alessio Mosca, Davide Arillotta, Giovanni Martinotti and Fabrizio Schifano picture_as_pdf
  • Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and ‘Smart Drug’ Use and Misuse. (2025) Fabrizio Schifano, Stefania Bonaccorso, Davide Arillotta, John Martin Corkery, Giuseppe Floresta, Gabriele Duccio Papanti and Amira Guirguis
  • Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data. (2025) Stefania Chiappini, Alessio Mosca, Duccio G Papanti, John Martin Corkery, Amira Guirguis, Davide Arillotta, Giovanni Martinotti and Fabrizio Schifano picture_as_pdf
  • Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues. (2025) Fabrizio Schifano, Stefania Bonaccorso, Davide Arillotta, Amira Guirguis, John Martin Corkery, Giuseppe Floresta, Gabriele Duccio Papanti Pelletier, Norbert Scherbaum and Nicolò Schifano
  • Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT 7 and κ‐opioid receptors' molecular interactions and isosteric replacement. (2025) Giuseppe Floresta, Alberto Granzotto, Vincenzo Patamia, Davide Arillotta, Gabriele D. Papanti, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
  • From Veterinary Medicine to Illicit Drug Supply: Utilising Social Media to Explore the Rising Emergence of Veterinary Medicines in Human Health. (2025) Josie Dunn, Fabrizio Schifano, Ed Dudley, Davide Arillotta and Amira Guirguis picture_as_pdf
  • Screening and Quantification of the Synthetic Cannabinoid Receptor Agonist 5F-MDMB-PINACA from Seized Prison Paper Using Ultra-Performance Liquid Chromatography-Mass Spectrometry Approaches. (2025) Giorgia Vaccaro, Jacqueline L. Stair, Stewart B. Kirton, Daniel Baker and Amira Guirguis picture_as_pdf
  • Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review. (2024) Stefania Chiappini, Pietro Domenico Gramuglia, Alessio Mosca, Clara Cavallotto, Andrea Miuli, John Martin Corkery, Amira Guirguis, Fabrizio Schifano and Giovanni Martinotti
  • Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS). (2024) Josie Dunn, Fabrizio Schifano, Ed Dudley and Amira Guirguis
  • Exploring the Confluence of Animal Medicine and its Implications for Human Health : A Systematic Literature Review. (2024) Josie Dunn, Fabrizio Schifano, Ed Dudley and Amira Guirguis
  • New trends of drug abuse in custodial settings: a systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances. (2024) Stefania Chiappini, Giorgia Vaccaro, Alessio Mosca, Andrea Miuli, Gianfranco Stigliano, Giulia Stefanelli, Giulia Giovannetti, Rosalba Carullo, Giacomo d'Andrea, Francesco Di Carlo, Clara Cavallotto, Mauro Pettorruso, Gilberto Di Petta, John Martin Corkery, Amira Guirguis, Jacqueline L. Stair, Giovanni Martinotti, Seena Fazel and Fabrizio Schifano picture_as_pdf
  • Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. (2024) Davide Arillotta, Giuseppe Floresta, G. Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti and Fabrizio Schifano
  • Exploring the Association Between Suicidal Thoughts, Self-Injury, and GLP-1 Receptor Agonists in Weight Loss Treatments: Insights from Pharmacovigilance Measures and Unmasking Analysis. (2024) Amira Guirguis, Stephania Chiappini, P G Duccio Papanti, Rachel Vickers-Smith, Daniel Harris, John Corkery, Davide Arillotta, Giuseppe Floresta, Giovanni Martinotti and Fabrizio Schifano
  • Semaglutide as a Possible Calmodulin Binder: Ligand-Based Computational Analyses and Relevance to Its Associated Reward and Appetitive Behaviour Actions. (2024) Giuseppe Floresta, Davide Arillotta, Valeria Catalani, G. Duccio Papanti Pelletier, John Corkery, Amira Guirguis and Fabrizio Schifano
  • Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. (2024) Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John M Corkery, Jacqueline L Stair, Fabrizio Schifano and Amira Guirguis
  • Exploring the understanding, source of availability and level of access of cognitive enhancers among university students in the United Arab Emirates: a qualitative study. (2023) Safia Sharif, Suzanne Fergus, Amira Guirguis, Nigel Smeeton and Fabrizio Schifano picture_as_pdf
  • Stimulant and hallucinogenic novel psychoactive substances; an update. (2023) Fabrizio Schifano, Alessandro Vento, Norbert Scherbaum and Amira Guirguis
  • Exploring the Nexus of Binge Eating Disorder (BED), New Psychoactive Substances (NPS), and Misuse of Pharmaceuticals: Charting a Path Forward. (2023) Stefania Chiappini, G. Duccio Papanti Pelletier, Rachel Vickers-Smith, John Corkery, Amira Guirguis, Giovanni Martinotti and Fabrizio Schifano
  • GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. (2023) Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
  • Obstacles to Treatment retention in Opioid Use Disorder: An International Substance Use Disorder Treatment Worker Survey. (2023) Matthew Jones, Amira Guirguis, Alan Watkins, Ceri Bradshaw, Lily Mohamed and Fabrizio Schifano description
  • Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. (2023) Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
  • Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service. (2023) Anthony Mullin, Mark Scott, Giorgia Vaccaro, Rosalind Gittins, Salvatore Ferla, Fabrizio Schifano and Amira Guirguis
  • In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines. (2023) Valeria Catalani, Giuseppe Floresta, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Vincenzo Abbate and Fabrizio Schifano
  • Knowledge and use of over-the-counter drugs in Italy: a survey-based study in the general population. (2022) Stephania Chiappini, Franca Ceci, Alessio Mosca, Francesco Di Carlo, Julius Burkauskas, Mauro Pettorruso, Giovanni Martinotti, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano and Massimo di Giannantonio
  • Alprazolam-related deaths in Scotland, 2004-2020. (2022) John Martin Corkery, Amira Guirguis, Stefania Chiappini, Giovanni Martinotti and Fabrizio Schifano picture_as_pdf
  • Designer Benzodiazepines’ Activity on Opioid Receptors: A Docking Study. (2022) Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento and Fabrizio Schifano
  • Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). (2022) Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Daniel R. Harris and Fabrizio Schifano
  • A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. (2022) Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti and Fabrizio Schifano
  • Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals. (2022) Fabrizio Schifano, Valeria Catalani, Safia (Sophia) Sharif, Flavia Napoletano, John Corkery, Davide Arillotta, Suzanne Fergus, Alessandro Vento and Amira Guirguis
  • NPS detection in Prison: a Systematic Literature Review of Use, Drug Form, and Analytical Approaches. (2022) Jacqueline Stair, Giorgia Vaccaro, Amira Guirguis, Stewart Kirton and Anna Massariol
  • Misuse of anticholinergic medications: a systematic review. (2022) Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Semeraro, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Fabrizio Schifano and Massimo di Giannantonio picture_as_pdf
  • Assessing prevalence, knowledge and use of cognitive enhancers among university students in the United Arab Emirates: A quantitative study. (2022) Safia Sharif, Suzanne Fergus, Amira Guirguis, Nigel Smeeton and Fabrizio Schifano
  • Psychonauts’ psychedelics: a systematic, multilingual, web-crawling exercise. (2021) Valeria Catalani, John Martin Corkery, Amira Guirguis, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Alessandro Vento and Fabrizio Schifano
  • The psychonauts’ benzodiazepines; quantitative structure-activity relationship (QSAR) analysis and docking prediction of their biological activity. (2021) Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum and Fabrizio Schifano description
  • Covid-19 pandemic impact on substance misuse: a social media listening, mixed method analysis. (2021) Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum and Fabrizio Schifano
  • New Psychoactive Substances and suicidality: a systematic review of the current literature. (2021) Stefania Chiappini, Alessio Mosca, A. Miuli, Monica Chiara Santovito, Laura Orsolini, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Giovanni Martinotti, Massimo di Giannantonio and Fabrizio Schifano description
  • Focus on over-the-counter drugs’ misuse; a systematic review on antihistamines, cough medicines and decongestants. (2021) Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, Monica Chiara Santovito, Alessio Mosca, Maria Chiara Santovito, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Massimo di Giannantonio and Giovanni Martinotti
  • New Psychoactive Substances (NPS) and Serotonin Syndrome onset: a Systematic Review. (2021) Fabrizio Schifano, Stephania Chiappini, John Corkery, Norbert Scherbaum, Flavia Napoletano, Davide Arillotta, Valeria Catalani, Alessandro Vento, Mauro Pettorruso, Giovanni Martinotti, Massimo di Giannantonio and Amira Guirguis
  • The e-psychonaut drugs’ psychopharmacology. (2021) Fabrizio Schifano, Stephania Chiappini, John Martin Corkery, Norbert Scherbaum and Amira Guirguis
  • The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review. (2021) Safia Sharif, Amira Guirguis, Suzanne Fergus and Fabrizio Schifano
  • Identifying new/emerging psychoactive substances at the time of COVID-19; a web-based approach. (2021) Valeria Catalini, Davide Arillotta, John Martin Corkery, Amira Guirguis, Alessandro Vento and Fabrizio Schifano description
  • The benzydamine experience: A systematic review of Benzydamine abuse. (2021) Stephania Chiappini, Andrea Miuli, Alessio Mosca, Mauro Pettorruso, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Massimo di Giannantonio and Fabrizio Schifano
  • Beyond the Purple Drank. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports. (2021) Stefania Chiappini, Fabrizio Schifano, John Martin Corkery and Amira Guirguis
  • Misuse of prescription and over-the-counter drugs to obtain illicit highs: how pharmacists can prevent abuse. (2020) Stefania Chiappini, Amira Guirguis, John Corkery and Fabrizio Schifano
  • What about drug checking? Systematic review and netnographic analysis of social media. (2020) Amira Guirguis, Isma Moosa, Rosalind Gittins and Fabrizio Schifano
  • The psychonauts' world of cognitive enhancers. (2020) Flavia Napoletano, Fabrizio Schifano, John Martin Corkery, Amira Guirguis, Davide Arillotta, Caroline Zangani and Alessandro Vento picture_as_pdf
  • Piloting the UK's First Home-Office-Licensed Pharmacist-Led Drug Checking Service at a Community Substance Misuse Service. (2020) Amira Guirguis, Rosalind Gittins and Fabrizio Schifano
  • COVID-19: The hidden impact on mental health and drug addiction. (2020) Stefania Chiappini, Amira Guirguis, Ann John, John Corkery and Fabrizio Schifano description
  • Novel opioids: systematic web crawling within the e-psychonauts’ scenario. (2020) Davide Arillotta, Fabrizio Schifano, Flavia Napoletano, Caroline Zangani, Liam Gilgar, Amira Guirguis, John Martin Corkery, E Aguglia and alessandro vento
  • Exploring the baseline knowledge and experience of healthcare professionals in the United Kingdom on Novel Psychoactive Substances. (2020) Amira Guirguis, Nigel Smeeton, Hadar Zaman, Anne-Marie Felice, Stephanie Bancroft, Rosalind Gittins, Gill Hawksworth, John Corkery and Fabrizio Schifano picture_as_pdf
  • The e-psychonauts’ ‘Spiced’ World; assessment of the synthetic cannabinoids’ information available online. (2020) Caroline Zangani, Fabrizio Schifano, Flavia Napoletano, Davide Arillotta, Liam Gilgar, Amira Guirguis, John Martin Corkery, Orsola Gambini and Alessandro Vento
  • Focus on clozapine withdrawal- and misuse-related cases, as reported to the European Medicines Agency (EMA) pharmacovigilance database. (2020) Stephania Chiappini, Fabrizio Schifano, John Martin Corkery and Amira Guirguis description
  • 'New/Designer Benzodiazepines': an analysis of the literature and psychonauts’ trip reports. (2020) Laura Orsolini, John Corkery, Stephania Chiappini, Amira Guirguis, Alessandro Vento, Domenico De Berardis, Duccio Papanti and Fabrizio Schifano
  • Commentary on: Attafi IM, Albeishy MY, Oraiby ME, Khardali IA, Shaikhain GA, Fageeh MM. Postmortem Distribution of Cathinone and Cathine in Human Biological Specimens in a Case of Death Associated with Khat Chewing. Arab J Forensic Sci Forensic Med. 2018 Jun 7;1(7). (2019) John Corkery, Fabrizio Schifano and Amira Guirguis description
  • The use of new psychoactive substances (NPS) in young people and their role in mental health care : a systematic review. (2019) Laura Orsolini, Stephania Chiappini, John Corkery, Amira Guirguis, Duccio Papanti and Fabrizio Schifano
  • The clinical challenges of synthetic cathinones. (2019) Fabrizio Schifano, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Liam Gilgar, Amira Guirguis, John Corkery and Alessandro Vento
  • New/emerging psychoactive substances and associated psychopathological consequences. (2019) Fabrizio Schifano, Flavia Napoletano, Stephania Chiappini, Amira Guirguis, John Corkery, Stefania Bonaccorso, Angelo Ricciardi, Norbert Scherbaum and alessandro vento
  • New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues. (2019) Fabrizio Schifano, Flavia Napoletano, Stephania Chiappini, Laura Orsolini, Amira Guirguis, John Martin Corkery, Stefania Bonaccorso, Angelo Ricciardi, Norbert Scherbaum and alessandro vento
  • An Insight into Z-Drug Abuse and Dependence : An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. (2019) Fabrizio Schifano, Stefania Chiappini, John Martin Corkery and Amira Guirguis description
  • Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems. (2019) Fabrizio Schifano, Stephania Chiappini, John Corkery and Amira Guirguis picture_as_pdf
  • Novel psychoactive substances: understanding the new illegal drug market. (2018) Amira Guirguis description
  • Detection of Newly Emerging Psychoactive Substances Using Raman Spectroscopy and Chemometrics. (2018) Jesus Calvo-Castro, Amira Guirguis, Eleftherios Samaras, Mire Zloh, Stewart Kirton and Jacqueline Stair
  • Psychedelic Fauna for Psychonaut Hunters : A Mini-Review. (2018) Laura Orsolini, Michela Ciccarese, Duccio Papanti, Domenico De Berardis, Amira Guirguis, John Corkery and Fabrizio Schifano picture_as_pdf
  • Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. (2018) Fabrizio Schifano, Stefania Chiappini, John Corkery and Amira Guirguis description
  • Exploration of the use of new psychoactive substances by individuals in treatment for substance misuse in the UK. (2018) Rosalind Gittins, Amira Guirguis, Fabrizio Schifano and Ian Maidment
  • The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. (2017) Laura Orsolini, Duccio Papanti, Domenico De Berardis, Amira Guirguis, John Corkery and Fabrizio Schifano
  • Drowning in Diversity? A systematic way of clustering a representative set of new psychoactive substances. (2017) Mire Zloh, Eleftherios Samaras, Jesus Calvo-Castro, Amira Guirguis, Jacqueline Stair and Stewart Kirton
  • New Psychoactive Substances: A Public Health Issue. (2017) Amira Guirguis
  • Intended and Unintended Use of Cathinone Mixtures. (2017) Amira Guirguis, John Corkery, Jacqueline Stair, Stewart Kirton, Mire Zloh and Fabrizio Schifano
  • Method Development for the Determination of Elements in Hypericum perforatum L. (St John’s wort) Herb and Preparations using ICP-OES and Microwave Digestion. (2017) Jade Owen, Sara Evans, Amira Guirguis, Kathryn Kellett and Jacqueline Stair
  • Identification of new psychoactive substances (NPS) using handheld Raman Spectroscopy employing both 785 and 1064 nm laser sources. (2017) Amira Guirguis, Sarah Girotto, Benedetta Berti and Jacqueline Stair
  • Ethnic disparities in the uptake of pharmacy services. (2016) Stephanie Bancroft, Christine Heading, Amira Guirguis, Shreya Shah, Usha Shah and Darush Attar-Zadeh description
  • Legal highs and lows. (2016) Amira Guirguis
  • Pharmacy consultation outcomes during a lung cancer awareness campaign. (2015) Christine Heading, Amira Guirguis, Shreya Shah and Stephanie Bancroft description
  • Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists. (2015) Amira Guirguis, John Corkery, Jacqueline Stair, Stewart Kirton, Mire Zloh, Christine Goodair, Fabrizio Schifano and Colin Davidson
  • Analysis of 'legal high' substances and common adulterants using handheld spectroscopic techniques. (2015) Sulaf Assi, Amira Guirguis, S. Halsey, S. Fergus and J. L. Stair
  • Presence of metals in herbal extracts. (2012) Amira Guirguis, Jade Owen and Jacqueline Stair
    • Book Section
  • Synthetic Cannabinoids, the largest and most diverse group of novel psychoactive substances. (2024) P G Duccio Papanti, Laura Orsolini, John Martin Corkery, Stefania Chiappini, Amira Guirguis, Alessando Vento and Fabrizio Schifano picture_as_pdf
  • Substance Use Disorders and Violence. (2020) Fabrizio Schifano, Caroline Zangani, Stephania Chiappini, Amira Guirguis, Stefania Bonaccorso and John Corkery description
  • Synthetic cathinones – prevalence and motivations for use. (2018) John Corkery, Amira Guirguis, Duccio Papanti, Laura Orsolini and Fabrizio Schifano
  • New Psychoactive Substances. (2017) Amira Guirguis and M. Jayne Lawrence description
    • Conference or Workshop Item
  • Community Pharmacist interventions and improved COPD management. (2016) Darush Attar-Zadeh, Amira Guirguis, Christine Heading, Shreya Shah, Usha Shah and Stephanie Bancroft description
  • Identification of new psychoactive substances using Raman spectroscopy: handheld and computational approaches. (2016) Amira Guirguis, Stewart Kirton, Mire Zloh, Eleftherios Samaras, Sarah Girotto, Benedetta Berti and Jacqueline Stair description
    • Book
  • Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon. (2019) Ornella Corazza, Robert Chilcott, Giovanni Martinotti, John Corkery, Amira Guirguis, Mire Zloh, Shanna Marrinan and Valeria Catalani
    • Thesis
  • Identification and Classification of New Psychoactive Substances Using Raman Spectroscopy and Chemometrics. (2017) Amira Guirguis
    • Other
  • An investigation into the relationship(s) between the different chemical classes of synthetic cathinones and their effects: desired, adverse and toxic. (2017) John Corkery, Amira Guirguis, Laura Orsolini, Duccio Papanti and Fabrizio Schifano
  • Substance use and misuse - Legal highs. (2016) Amira Guirguis, Rosalind Gittins, John Corkery and Fabrizio Schifano picture_as_pdf
  • Written evidence to the psychoactive substances inquiry. (2015) Amira Guirguis and Christine Heading
  • Novel psychoactive substances: understanding the new illegal drug market. (2018) Amira Guirguis
    • This list was generated on Sun Oct 4 01:57:55 2026 BST.